These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6198185)

  • 1. Absence of cell surface fixation of a monoclonal antibody detectable by conventional immunoassays does not exclude expression of and interaction with the corresponding antigenic determinant.
    Layet C; Le Bouteiller PP; Olive D; Mishal Z; Caillol D; Kourilsky FM; Jordan BR; Lemonnier FA
    Eur J Immunol; 1984 Jan; 14(1):99-102. PubMed ID: 6198185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of LMTK- cells with purified class I genes. V. Antibody-induced structural modification of HLA class I molecules results in potentiation of the fixation of a second monoclonal antibody.
    Lemonnier FA; Le Bouteiller PP; Olive D; Malissen B; Mishal Z; Layet C; Dubreuil J; Caillol DH; Kourilsky FM; Jordan BR
    J Immunol; 1984 Mar; 132(3):1176-82. PubMed ID: 6198381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between murine beta 2-microglobulin and HLA class I heavy chains results in serologically detectable conformational changes of both chains.
    Ferrier P; Layet C; Caillol DH; Jordan BR; Lemonnier FA
    J Immunol; 1985 Aug; 135(2):1281-7. PubMed ID: 2409144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.
    Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C
    Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation.
    De Felice M; Turco MC; Giarrusso PC; Corbo L; Pizzano R; Martinelli V; Ferrone S; Venuta S
    J Immunol; 1987 Oct; 139(8):2683-9. PubMed ID: 2443568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
    Quackenbush EJ; Letarte M
    J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes.
    Achour A; Begue B; Gomard E; Paul P; Sayagh B; Van Pel A; Levy JP
    Eur J Immunol; 1986 Jun; 16(6):597-604. PubMed ID: 3522244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation of three subsets of class I human T antigens (HTA) on Molt-4 cells: serologic and regulatory relationship to HLA class I antigens.
    Kahn-Perles B; Wietzerbin J; Caillol DH; Lemonnier F
    J Immunol; 1985 Mar; 134(3):1759-65. PubMed ID: 2578520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of the passive antibody-induced suppression of the humoral immune response of mice to surface antigens on human cells.
    Gadd SJ; Brogan MP; Ashman LK
    Immunology; 1985 Feb; 54(2):223-31. PubMed ID: 2578428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syngeneic anti-idiotypic antisera to murine monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens.
    Perosa F; Tsujisaki M; Ferrone S
    J Immunol; 1987 Apr; 138(7):2202-7. PubMed ID: 2435792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.
    MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM
    J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligation of HLA class II molecules promotes sensitivity to CD95 (Fas antigen, APO-1)-mediated apoptosis.
    Yoshino T; Cao L; Nishiuchi R; Matsuo Y; Yamadori I; Kondo E; Teramoto N; Hayashi K; Takahashi K; Kamikawaji N
    Eur J Immunol; 1995 Aug; 25(8):2190-4. PubMed ID: 7545111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody CI-panHu defines a pan-human cell-surface antigen unique to higher primates.
    de Kretser TA; Lee GT; Thorne HJ; Jose DG
    Immunology; 1986 Apr; 57(4):579-85. PubMed ID: 2420708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological analysis of the dissociation process of HLA-B and C class I molecules.
    Gillet AC; Pérarnau B; Mercier P; Lemonnier FA
    Eur J Immunol; 1990 Apr; 20(4):759-64. PubMed ID: 2189736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. Cloning and preliminary functional studies.
    Gil ML; Vita N; Lebel-Binay S; Miloux B; Chalon P; Kaghad M; Marchiol-Fournigault C; Conjeaud H; Caput D; Ferrara P
    J Immunol; 1992 May; 148(9):2826-33. PubMed ID: 1573270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of HLA epitopes recognized by H-2-restricted cytotoxic T lymphocytes specific for HLA using recombinant genes and synthetic peptides.
    Pala P; Corradin G; Strachan T; Sodoyer R; Jordan BR; Cerottini JC; Maryanski JL
    J Immunol; 1988 Feb; 140(3):871-7. PubMed ID: 2448379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of monoclonal antibodies reactive with porcine PBL.
    Pescovitz MD; Lunney JK; Sachs DH
    J Immunol; 1984 Jul; 133(1):368-75. PubMed ID: 6609988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of expression of mouse macrophage surface antigens by monoclonal antibodies.
    Collet B; Martin A; Merdrignac G; Genetet B; Toujas L
    Immunology; 1985 Nov; 56(3):543-8. PubMed ID: 2416679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
    Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
    Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.